Microthin-Pii Bipolar Pulse Gen. #0623
510(k) K803034
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK803034 | Date22 Dec 1980 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXY
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3610
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Microthin-PII Bipolar Pulse Generator #0623 is an implantable pacemaker pulse-generator, designed to regulate cardiac rhythm by delivering electrical impulses to the heart. It falls under the classification of a Class III device, requiring pre-market approval due to its role in life-sustaining or supporting functions.
This device is intended for single-use implantation and is regulated under FDA 510(k) clearance (K803034) with a traditional review pathway. Supplied sterile and intended for cardiovascular use, it adheres to regulatory standards outlined in 870.3610. The device is manufactured by Cardiac Pacemakers, Inc., now part of Boston Scientific’s cardiac rhythm management portfolio.
Other devices from Cardiac Pacemakers, Inc.
Questions
AI-generated answers, 18 Sep 2026
Is the Microthin-PII Bipolar Pulse Generator #0623 designed for reuse or is it intended for single-use implantation only?
The Microthin-PII Bipolar Pulse Generator #0623 is explicitly designed for single-use implantation. This is stated directly in the device description, which specifies it is intended for one-time use after implantation.
How is the Microthin-PII Bipolar Pulse Generator #0623 supplied, and is it sterile upon receipt?
The device is supplied sterile and ready for use, as noted in the description. Since it is an implantable medical device, sterility is a critical requirement to prevent infection during cardiovascular procedures.
What regulatory pathway was used for FDA clearance of this device, and what does that mean for its approval status?
The Microthin-PII Bipolar Pulse Generator #0623 was cleared via the FDA 510(k) pathway under the traditional review process, with a decision of *Substantially Equivalent* (SESE). This means the FDA determined it is as safe and effective as a legally marketed predicate device, though it remains a Class III device due to its life-sustaining role. The clearance number is K803034.
What medical specialty is primarily responsible for the use of this device, and what type of patients would it typically serve?
The device falls under the Cardiovascular medical specialty, as indicated by its regulatory filings. It is intended for patients requiring cardiac rhythm regulation, specifically those with bradycardia or other conditions necessitating an implantable pacemaker to deliver electrical impulses to the heart.
Does this device have multiple models or sizes, or is it a single-unit design?
The provided data does not specify multiple models or sizes for the Microthin-PII Bipolar Pulse Generator #0623—only the specific unit number (#0623) is mentioned. However, the associated FEI numbers (e.g., 3002807576) suggest it may have been distributed in various lot or batch configurations, but no size or model variations are detailed in the description.